Bergen Brunswig Announces Exclusive Logistics Partnership With EGL, Inc.

Business Editors

ORANGE, Calif.--(BUSINESS WIRE)--July 27, 2000

Bergen Brunswig Drug Company (BBDC), a subsidiary of Bergen Brunswig Corporation (NYSE: BBC), today announced an exclusive agreement under which EGL, Inc. (NASDAQ:EAGL), the nation's largest and fastest growing domestic air freight forwarder, will provide Bergen with logistics and transportation services.

Available to Bergen is an innovative logistical concept that will enable Bergen to significantly decrease the costs and risks associated with transporting goods while improving supply chain management.

"We are confident that a partnership with Eagle will enhance our ability to reduce carrying costs of inventory by speeding the time to market and apply a time-definite approach for our vendors and customers," said Brent Martini, president, Bergen Brunswig Drug Company. "We were looking for a model to help us manage transportation costs and give us visibility and control over our supply chain and we believe we have found it with Eagle."

Added EGL Chairman and CEO James R. Crane, "This relationship with Bergen Brunswig underscores EGL's growing capability in providing logistics services to a wide range of its customers."

Houston-based EGL operates under the name EGL Eagle Global Logistics. EGL's dedication to providing superior flexibility and fewer shipping restrictions on a price competitive basis has made it a leading provider of airfreight forwarding and other transportation and logistics services. Its network of 92 terminals in nine countries, features state-of-the-art information systems designed to maximize cargo management efficiency and customer satisfaction. It's fiscal revenues totaled more than $595 million. The company's shares are traded on the NASDAQ National Market under the symbol "EAGL."

Bergen Brunswig Corporation, headquartered in Orange County, California, is a leading supplier of pharmaceuticals, medical-surgical supplies and specialty healthcare products as well as information management solutions and consulting services. Bergen's customers include the nation's healthcare providers (hospitals, nursing homes, physicians), drug stores, manufacturers and patients. Through its subsidiaries, Bergen provides product distribution; logistics; pharmacy management programs; and Internet fulfillment strategies designed to reduce costs and improve patient outcomes across the entire healthcare spectrum.

Certain of the information set forth in this press release may constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 and are subject to risks, uncertainties and other factors which could cause actual results to differ materially from those projected or implied. Such statements may be identified by the use of forward-looking language such as "may," "will," "should," "expect," "anticipate," "estimate" or "continue" or the negatives or other variations thereof or other similar terminology. Such risks and uncertainties include the risks described in exhibit 99 to the Company's Quarterly Report on Form 10Q for the quarter ended June 30, 1999 and in other reports and exhibits filed with the Securities and Exchange Commission.

Bergen Brunswig press releases are available on the company's website at www.bergenbrunswig.com.